Astellas Pharma Inc. Site Map
 
 

Astellas Pharma US, Inc. is committed to providing patients, customers, community and employees with a bright future by changing tomorrow. Our commitment is made possible because we are a different kind of pharmaceutical company. This is apparent not only in what we do, but how we do it.

About Astellas In the U.S.

Headquartered in Deerfield, Illinois, Astellas has locations across North America.

North American Locations

 
Topics
  • Find out about our expanding oncology pipeline.

 
Information
January 06, 2012
ASTELLAS AND THERAVANCE ANNOUNCE TERMINATION OF LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT FOR VIBATIV® (TELAVANCIN) FOR INJECTION - PDF 82KB
January 03, 2012
AVEO AND ASTELLAS ANNOUNCE TIVOZANIB SUCCESSFULLY DEMONSTRATED PROGRESSION-FREE SURVIVAL SUPERIORITY OVER SORAFENIB IN PATIENTS WITH ADVANCED RENAL CELL CANCER IN PHASE 3 TIVO-1 TRIAL - PDF 57KB
December 21, 2011
ZOGENIX AND ASTELLAS AGREE TO END CO-PROMOTION FOR SUMAVEL DOSEPRO EFFECTIVE MARCH 31, 2012 - PDF 59.6KB
December 01, 2011
ASTELLAS ADDS TWO KEY SENIOR EXECUTIVES AT AGENSYS, INC. - PDF 55KB
November 11, 2011
ASTELLAS SIGNS UNITED NATIONS GLOBAL COMPACT - PDF 80KB
Follow us on :    Follow us on Twitter
 
Copyright © 2005 - 2009 Astellas Pharma US, Inc. Site Map  Privacy Policy  Legal Disclaimer  Contact Us